Mental Health Tech Company Neuroflow Raised a $20M Series B Amid Pandemic Growth
The coronavirus pandemic isn’t just one of public health, but mental health, as well. One Philly company has seen growth as it aims to combat these spikes in depression and anxiety.
NeuroFlow, a tech-enabled behavioral health platform has raised a $20 million Series B round of financing to keep up with the growth its seen this year, the company announced Wednesday. The round was lead by Phoenix-headquartered managed health care company Magellan Health, along with previous investors.
NeuroFlow closed a $7.5 million Series A at the end of 2019, with plans to bulk up its sales, marketing and data science departments. The company stands around 60 employees right now, with plans for more hires with the Series B funding, a spokesperson told Technical.ly.
As mental health resources largely turned virtual last year, NeuroFlow scaled its operations in data analytics, artificial intelligence and direct health record integrations. The company’s flagship software product — called EngageBH — allows clinicians to see data from wearable devices, assign tasks such as meditation or journaling for patients to complete at home, and send automated motivational emails.
Read the full article here.
